90,44 €*
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

 Buch
Sf Besorgungstitel | Versandkostenfrei
Foreword. Preface. Acknowledgments. Abbreviations. PartA I: INTRODUCTION. 1. The Importance of Cardiac Safety Assessments. 2. The Biological Basis of Adverse Drug Reactions. PartA II: CARDIAC FUNCTION AND PATHOLOGY. 3. Cardiac Structure and Function. 4. Cardiac Pathophysiology and Disease. SECTION III: DRUG DISCOVERY AND NONCLINICAL DEVELOPMENT. 5. Drug Discovery and Drug Design. 6. Nonclinical Development. SECTION IV: PREAPPROVAL CLINICAL DEVELOPMENT. 7. The Thorough QT/QTc Trial. 8. General Safety Assessments. SECTION V: POSTMARKETING ASSESSMENT METHODOLOGIES. 9. Therapeutic Use Trials and Meta-analyses. 10. Assessment Methodologies in Nonexperimental Postmarketing Surveillance. 11. Postmarketing Proarrythmic Cardiac Safety Assessments. 12. Generalized Cardiac Safety. SECTION VI: BEHAVIORAL DRUG SAFETY. 13. Medication Errors, Adherence, and Concordance. SECTION VII: INTEGRATIVE DISCUSSION. 14. Future Directions in Drug Safety. References. Index.
The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. "Integrated Cardiac Safety" provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.

Mehr zum Thema

    Medical / Nursing; MEDICAL / Cardiology; MEDICAL / Pharmacology

Produktdetails

Autor: J. Rick Turner
ISBN-13: 9780470229644
ISBN: 0470229640
Einband: Buch
Seiten: 470
Gewicht: 839 g
Format: 236x157x25 mm
Sprache: Englisch
Autor: J. Rick Turner, Todd A. Durham
J. Rick Turner, PhD, PGCE, MICR, is Chairman, Department of Clinical Research at Campbell University School of Pharmacy. Dr. Turner has extensive teaching, research, and pharmaceutical credentials and more than a dozen awards and honors, including a Commit to Product Development Award from GlaxoSmithKline. He is the author of seven books and more than 100 journal articles and published abstracts. Todd A. Durham, MS, is Senior Director of Biostatistics and Data Management at Inspire Pharmaceuticals. Prior to joining Inspire, Mr. Durham served as Associate Director of Biostatistics at Quintiles, Inc. Mr. Durham has made significant statistical contributions to six NDA submissions and has been involved with five presentations to FDA advisory committees.

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.

 

Rezensionen

Autor: J. Rick Turner
ISBN-13:: 9780470229644
ISBN: 0470229640
Erscheinungsjahr: 01.11.2008
Verlag: JOHN WILEY & SONS INC
Gewicht: 839g
Seiten: 470
Sprache: Englisch
Sonstiges: Buch, 236x157x25 mm